Home › Funds › Frank, Rimerman Advisors LLC › JNJ

Frank, Rimerman Advisors LLC position in JNJ

JOHNSON JOHNSON · Health Care

Frank, Rimerman Advisors LLC reported holding 51,796 shares of JNJ (JOHNSON JOHNSON) in its Q3 2026 13F filing — a position valued at US$13.7M, representing 0.76% of its reported portfolio and ranking #19 among its reported holdings. Frank, Rimerman Advisors LLC has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)51.80K sh
Reported value held$13.71M
Portfolio Weight0.76%
First reportedQ3 2023
Last changeHold
Updated2026-10-16

Last updated: 2026-10-16 · Source: SEC EDGAR Form 13F-HR

How Frank, Rimerman Advisors LLC's JNJ position evolved

Frank, Rimerman Advisors LLC first disclosed a stake in JNJ in Q3 2023 at 1,649 shares (US$257K). The position peaked in Q3 2026 at 51,796 shares, worth US$13.7M. Across 13 filings, Frank, Rimerman Advisors LLC increased the stake 6 time(s), trimmed it 0 time(s) and left it unchanged 6 time(s). The most recent filing (Q3 2026) shows 51,796 shares valued at US$13.7M. Notable position changes include a 1812% increase in Q2 2024 (shares rose 11% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.65K $256.86K New
Q4 2023 1.65K $258.59K Hold
Q1 2024 1.65K $261.08K Hold
Q2 2024 31.54K $4.61M Add
Q3 2024 35.84K $5.81M Add
Q4 2024 35.94K $5.20M Hold
Q1 2025 39.83K $6.61M Add
Q2 2025 46.41K $7.09M Add
Q3 2025 47.94K $8.89M Add
Q4 2025 48.00K $9.93M Hold
Q1 2026 48.01K $11.74M Hold
Q2 2026 51.67K $13.12M Add
Q3 2026 51.80K $13.71M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON JOHNSON) is a Health Care company. 33 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$39.93B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →

FAQ

How long has Frank, Rimerman Advisors LLC held JNJ?

Frank, Rimerman Advisors LLC has disclosed JNJ holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Frank, Rimerman Advisors LLC's current position in JNJ?

As of Q3 2026, Frank, Rimerman Advisors LLC holds 51.80K shares of JNJ (JOHNSON JOHNSON), valued at $13.71M, representing 0.76% of its reported portfolio and ranking #19.

Has Frank, Rimerman Advisors LLC been buying or selling JNJ?

In the latest 13F filing (Q3 2026), Frank, Rimerman Advisors LLC held unchanged its position in JNJ. The position peaked in Q3 2026 at 51.80K shares.

Which other funds hold JNJ?

Other major institutional holders of JNJ include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 33 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.